Dexcom Inc. Stock
€54.00
Your prediction
Dexcom Inc. Stock
Pros and Cons of Dexcom Inc. in the next few years
Pros
Cons
Performance of Dexcom Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Dexcom Inc. | 0.370% | 3.462% | -5.365% | -8.798% | -6.141% | -52.212% | -37.259% |
| Baxter International | -0.730% | 2.206% | 10.017% | -39.724% | -3.327% | -61.772% | -78.501% |
| Teleflex Inc. | 0.000% | 7.273% | 29.670% | 1.724% | 15.686% | -50.833% | -67.222% |
| Dentsply Sirona Inc. | -1.920% | -0.779% | 2.043% | -13.055% | 6.257% | -72.754% | -81.371% |
Comments
News
2 Growth Stocks to Hold for the Next Decade
Over the past year, Intuitive Surgical (NASDAQ: ISRG) and DexCom (NASDAQ: DXCM) have faced headwinds, and have lagged the stock market as a result. Shares of the former are down 13% over the
Got $10,000? I Think DexCom Stock Could Be a Quiet Winner of the GLP‑1 Wars
Many pharmaceutical companies are looking to develop and market the now highly popular GLP-1 drugs, which help treat diabetes, help patients lose weight, and reduce their risk of a range of
DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price?
It's been a tough year for DexCom (NASDAQ: DXCM), whose stock price is down 25% since the start of 2025. It's a surprising performance, given that the overall stock market has been doing well; you


